Search

Displaying results 7381 - 7390 of 10000 in total
  1. Drug

    MaxAdFVIII

    go.drugbank.com/drugs/DB17713
    Experimental

    MaxAdFVIII is an adenoviral vector that expresses the full-length human Factor VIII (hFVIII) cDNA. First developed by GenStar, it is being investigated for the treatment of hemophilia.

  2. Drug

    CSIC002

    go.drugbank.com/drugs/DB18584
    Experimental

    CSIC002 is a small-molecule Sema-3A inhibitor. It is being investigated for the treatment of anterior ischemic optic neuropathy.

    Synonyms: NP-CSIC002
  3. Drug

    ALMB-0168

    go.drugbank.com/drugs/DB16926
    Investigational

    ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma.

  4. Drug

    Rotigaptide

    go.drugbank.com/drugs/DB13067
    Investigational

    Rotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.

  5. Drug

    BMS-690514

    go.drugbank.com/drugs/DB11665
    Investigational

    BMS-690514 has been investigated for the treatment of Breast Cancer.

  6. Drug

    Carnosine

    go.drugbank.com/drugs/DB11695
    Investigational

    Carnosine has been investigated for the treatment of Gulf War Illness.

  7. Drug

    Methyl isocyanate

    go.drugbank.com/drugs/DB12765
    Investigational

    Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.

  8. Drug

    Sepranolone

    go.drugbank.com/drugs/DB12972
    Investigational

    Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder.

  9. Drug

    Neladenoson bialanate

    go.drugbank.com/drugs/DB13138
    Investigational

    Neladenoson bialanate has been investigated for the treatment of Heart Failure.

  10. Drug

    PF-04447943

    go.drugbank.com/drugs/DB11953
    Investigational

    PF-04447943 has been investigated for the treatment of Alzheimer's Disease.